Interferon-alpha (IFN-alpha) was among the first cytokines studied and the
earliest to be used in clinical medicine for the treatment of viral infecti
ons and malignancies. Although the capacity of IFN-alpha to augment NK cell
cytotoxicity against virus-infected target cells or tumor cells is well es
tablished, the mechanism has not been fully elucidated. Here we report that
IFN-alpha stimulation of PBMC from healthy donors induces Fas (CD95) ligan
d (FasL) transcription and leads to increased cell surface Fast expression
exclusively on the NK cell fraction. Furthermore, IFN-alpha augments the Fa
st-mediated cytotoxicity of normal PBMC against Fas-sensitive lymphoid tumo
r cells. In the context of innate immunity, induction of Fast by IFN-alpha
can be viewed as an efficient mechanism to potentiate NR cell cytotoxicity
in the presence of harmful targets, such as virally infected or transformed
cells. (C) 2000 Academic Press.